Avexitide is a glucagon-like peptide-1 (GLP-1) antagtonist that competes with endogenous GLP-1 for binding to GLP-1 receptors, therby antagonizing the effects of excess GLP-1 secretion. Avexitide can be used to study postoperative hypoglycemia (PBH).
Usually ships within 24 hours.